Nanologica AB (NICA.XSTO) Financials
All currency values in kr millions unless otherwise noted
Scroll
| Income Statement | DEC 2025 | DEC 2024 | DEC 2023 | DEC 2022 | DEC 2021 |
|---|---|---|---|---|---|
| Revenues | |||||
| Revenue | kr 21 | kr 15 | kr 1 | kr 2 | kr 13 |
| Cost of Revenue | kr 17 | kr 10 | kr 2 | -kr 2 | kr 8 |
| Gross Profit | kr 4 | kr 4 | -kr 0 | kr 3 | kr 5 |
| Total Operating Expenses | kr 54 | kr 52 | kr 60 | kr 53 | kr 44 |
| Operating Income | -kr 49 | -kr 48 | -kr 60 | -kr 50 | -kr 39 |
| Non-Operating | |||||
| Net Interest Expense | -kr 4 | -kr 6 | -kr 6 | -kr 5 | -kr 3 |
| Income Tax Expense | kr 0 | kr 0 | kr 0 | kr 0 | kr 0 |
| Net Income | |||||
| Net Income | -kr 51 | -kr 66 | -kr 75 | -kr 55 | -kr 45 |
| Per Share Data | |||||
| Revenue Per Share | kr 0.24 | kr 0.29 | kr 0.04 | kr 0.05 | kr 0.44 |
| EPS (Basic) | -kr 0.57 | -kr 1.32 | -kr 2.08 | -kr 1.76 | -kr 1.53 |
| EPS (Diluted) | -kr 0.57 | -kr 1.32 | -kr 2.08 | -kr 1.76 | -kr 1.53 |
| Shares Outstanding | 89.1M | 49.5M | 36.1M | 31.4M | 29.3M |
Related stocks: Biotechnology
Spot a number that looks wrong?
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.